Mettler-Toledo International, Inc. (NYSE:MTD – Get Free Report) Director Elisha Finney sold 474 shares of the company’s stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $1,433.57, for a total value of $679,512.18. Following the sale, the director owned 311 shares in the company, valued at approximately $445,840.27. This represents a 60.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Mettler-Toledo International Trading Down 0.6%
MTD stock opened at $1,404.27 on Friday. The firm has a 50 day moving average of $1,334.60 and a 200-day moving average of $1,249.64. The firm has a market capitalization of $28.69 billion, a P/E ratio of 35.56, a price-to-earnings-growth ratio of 4.19 and a beta of 1.41. Mettler-Toledo International, Inc. has a 12 month low of $946.69 and a 12 month high of $1,471.06.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last posted its earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share for the quarter, topping analysts’ consensus estimates of $10.62 by $0.53. The business had revenue of $1.03 billion for the quarter, compared to analyst estimates of $997.36 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. Mettler-Toledo International’s revenue was up 7.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $10.21 EPS. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. Sell-side analysts predict that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.
Institutional Inflows and Outflows
Wall Street Analyst Weigh In
MTD has been the subject of several recent analyst reports. JPMorgan Chase & Co. boosted their target price on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a “neutral” rating in a research report on Thursday, October 9th. Evercore ISI upped their price objective on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 7th. Wells Fargo & Company raised their target price on shares of Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the company an “equal weight” rating in a research note on Monday, November 10th. Citigroup lifted their target price on shares of Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the company a “buy” rating in a research report on Monday, November 10th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Mettler-Toledo International in a report on Wednesday, October 8th. Five equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat.com, Mettler-Toledo International currently has an average rating of “Hold” and a consensus target price of $1,406.50.
Read Our Latest Research Report on Mettler-Toledo International
About Mettler-Toledo International
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
Further Reading
- Five stocks we like better than Mettler-Toledo International
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Meta’s Pain May Be Your Gain: Is This a Rare Buying Window?
- How to Invest in Biotech Stocks
- 3 Under-the-Radar AI Stocks to Buy on the Dip
- Pros And Cons Of Monthly Dividend Stocks
- Your Thanksgiving Playbook: 3 Stocks Set to Benefit From Football Fever
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
